Elixinol Wellness (Germany) Performance
| E8M Stock | EUR 0.02 0 10.00% |
Elixinol Wellness holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -5.97, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Elixinol Wellness are expected to decrease by larger amounts. On the other hand, during market turmoil, Elixinol Wellness is expected to outperform it. Use Elixinol Wellness information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Elixinol Wellness.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Wellness Limited are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Elixinol Wellness reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 12.6 M |
Elixinol |
Elixinol Wellness Relative Risk vs. Return Landscape
If you would invest 0.80 in Elixinol Wellness Limited on September 26, 2024 and sell it today you would earn a total of 1.40 from holding Elixinol Wellness Limited or generate 175.0% return on investment over 90 days. Elixinol Wellness Limited is currently producing 6.9773% returns and takes up 50.7406% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Elixinol, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Elixinol Wellness Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elixinol Wellness' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Elixinol Wellness Limited, and traders can use it to determine the average amount a Elixinol Wellness' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1375
| Best Portfolio | Best Equity | E8M | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 50.74 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Elixinol Wellness is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elixinol Wellness by adding it to a well-diversified portfolio.
Elixinol Wellness Fundamentals Growth
Elixinol Stock prices reflect investors' perceptions of the future prospects and financial health of Elixinol Wellness, and Elixinol Wellness fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elixinol Stock performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (1.72) % | |||
| Operating Margin | (1.63) % | |||
| Current Valuation | 1.96 M | |||
| Shares Outstanding | 316.27 M | |||
| Price To Book | 0.54 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 7.05 M | |||
| EBITDA | (9.28 M) | |||
| Cash And Equivalents | 27.74 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 250 K | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (14.07 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 13.48 M | |||
About Elixinol Wellness Performance
By analyzing Elixinol Wellness' fundamental ratios, stakeholders can gain valuable insights into Elixinol Wellness' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Elixinol Wellness has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Elixinol Wellness has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. ELIXINOL GLOBAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.Things to note about Elixinol Wellness performance evaluation
Checking the ongoing alerts about Elixinol Wellness for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elixinol Wellness help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elixinol Wellness is way too risky over 90 days horizon | |
| Elixinol Wellness has some characteristics of a very speculative penny stock | |
| Elixinol Wellness appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 7.05 M. Net Loss for the year was (10.57 M) with profit before overhead, payroll, taxes, and interest of 4.9 M. | |
| Elixinol Wellness Limited has accumulated about 27.74 M in cash with (14.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 16.0% of the company shares are held by company insiders |
- Analyzing Elixinol Wellness' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elixinol Wellness' stock is overvalued or undervalued compared to its peers.
- Examining Elixinol Wellness' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elixinol Wellness' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elixinol Wellness' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elixinol Wellness' stock. These opinions can provide insight into Elixinol Wellness' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Elixinol Stock analysis
When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |